Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Leukemia, Prolymphocytic, T-Cell × ruxolitinib × Clear all

Phase

Status

Recruiting 2 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Leukemia, Prolymphocytic, T-Cell 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Graft vs Host Disease 1

Interventions

venetoclax 1 ruxolitinib 1 Cladribine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07311746 2025-12-31

Phase Ib/II Trial of Cladribine/Ruxolitinib/Venetoclax in Patients With Relapsed/Refractory T-cell Prolymphocytic Leukemia

M.D. Anderson Cancer Center

Phase 1/2 Not yet recruiting

LymphoidOther hematologic neoplasm

Leukemia, Prolymphocytic, T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡